Recent advances in viral evasion of the MHC Class I processing pathway

Current Opinion in Immunology

Volumn 40, Issue , 2016, Pages 43-50

  Schuren, Anouk B C ^a   Costa, Ana I ^a   Wiertz, Emmanuel J H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; ESCRT PROTEIN; EVASIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG; VIRUS PROTEIN; HLA ANTIGEN CLASS 1; VIRUS ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CD8+ T LYMPHOCYTE; COWPOX VIRUS; CROSS PRESENTATION; DOWN REGULATION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; EPSTEIN BARR VIRUS; HERPESVIRIDAE; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 7; IMMUNE EVASION; NATURAL KILLER CELL; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; TRANS GOLGI NETWORK; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING; UBIQUITINATION; VIRUS; VIRUS INHIBITION; ANIMAL; CYTOTOXICITY; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE EVASION; KILLER CELLS, NATURAL; VIRUS DISEASES; VIRUSES;

EID: 84962743407     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2016.02.007     Document Type: Review

References (64)

1. Blum J.S., Wearsch P.A., Cresswell P. Pathways of antigen processing. Annu Rev Immunol 2013, 31:443-473.
2. Hansen T.H., Bouvier M. MHC class I antigen presentation: learning from viral evasion strategies. Nat Rev Immunol 2009, 9:503-513.
3. van de Weijer M.L., Luteijn R.D., Wiertz E.J. Viral immune evasion: lessons in MHC class I antigen presentation. Semin Immunol 2015, 27:125-137.
4. Verweij M.C., Horst D., Griffin B.D., Luteijn R.D., Davison A.J., Ressing M.E., Wiertz E.J. Viral inhibition of the transporter associated with antigen processing (TAP): a striking example of functional convergent evolution. PLoS Pathog 2015, 11:e1004743.
5. Alzhanova D., Edwards D.M., Hammarlund E., Scholz I.G., Horst D., Wagner M.J., Upton C., Wiertz E.J., Slifka M.K., Fruh K. Cowpox virus inhibits the transporter associated with antigen processing to evade T cell recognition. Cell Host Microbe 2009, 6:433-445.
6. Byun M., Verweij M.C., Pickup D.J., Wiertz E.J., Hansen T.H., Yokoyama W.M. Two mechanistically distinct immune evasion proteins of cowpox virus combine to avoid antiviral CD8 T cells. Cell Host Microbe 2009, 6:422-432.
7. Lin J., Eggensperger S., Hank S., Wycisk A.I., Wieneke R., Mayerhofer P.U., Tampe R. A negative feedback modulator of antigen processing evolved from a frameshift in the cowpox virus genome. PLoS Pathog 2014, 10:e1004554.
8. Luteijn R.D., Hoelen H., Kruse E., van Leeuwen W.F., Grootens J., Horst D., Koorengevel M., Drijfhout J.W., Kremmer E., Fruh K., et al. Cowpox virus protein CPXV012 eludes CTLs by blocking ATP binding to TAP. J Immunol 2014, 193:1578-1589.
9. Shastri N., Nagarajan N., Lind K.C., Kanaseki T. Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum. Curr Opin Immunol 2014, 26:123-127.
10. Kim S., Lee S., Shin J., Kim Y., Evnouchidou I., Kim D., Kim Y.K., Kim Y.E., Ahn J.H., Riddell S.R., et al. Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol 2011, 12:984-991.
11. Janssen L., Ramnarayan V.R., Aboelmagd M., Iliopoulou M., Hein Z., Majoul I., Fritzsche S., Halenius A., Springer S. The murine cytomegalovirus immunoevasin gp40 binds MHC class I molecules to retain them in the early secretory pathway. J Cell Sci 2015.
12. Byun M., Wang X., Pak M., Hansen T.H., Yokoyama W.M. Cowpox virus exploits the endoplasmic reticulum retention pathway to inhibit MHC class I transport to the cell surface. Cell Host Microbe 2007, 2:306-315.
13. McCoy WHt, Wang X., Yokoyama W.M., Hansen T.H., Fremont D.H. Structural mechanism of ER retrieval of MHC class I by cowpox. PLoS Biol 2012, 10:e1001432.
14. Nelson C.A., Epperson M.L., Singh S., Elliott J.I., Fremont D.H. Structural conservation and functional diversity of the poxvirus immune evasion (PIE) domain superfamily. Viruses 2015, 7:4878-4898.
15. Wiertz E.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., Ploegh H.L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 1996, 84:769-779.
16. Wiertz E.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., Ploegh H.L. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 1996, 384:432-438.
17. Stagg H.R., Thomas M., van den Boomen D., Wiertz E.J., Drabkin H.A., Gemmill R.M., Lehner P.J. The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER. J Cell Biol 2009, 186:685-692.
18. van de Weijer M.L., Bassik M.C., Luteijn R.D., Voorburg C.M., Lohuis M.A., Kremmer E., Hoeben R.C., LeProust E.M., Chen S., Hoelen H., et al. A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation. Nat Commun 2014, 5:3832.
19. van den Boomen D.J., Timms R.T., Grice G.L., Stagg H.R., Skodt K., Dougan G., Nathan J.A., Lehner P.J. TMEM129 is a Derlin-1 associated ERAD E3 ligase essential for virus-induced degradation of MHC-I. Proc Natl Acad Sci U S A 2014, 111:11425-11430.
20. Burr M.L., Cano F., Svobodova S., Boyle L.H., Boname J.M., Lehner P.J. HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation. Proc Natl Acad Sci U S A 2011, 108:2034-2039.
21. Hsu J.L., van den Boomen D.J., Tomasec P., Weekes M.P., Antrobus R., Stanton R.J., Ruckova E., Sugrue D., Wilkie G.S., Davison A.J., et al. Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141. PLoS Pathog 2015, 11:e1004811.
22. Hudson A.W., Blom D., Howley P.M., Ploegh H.L. The ER-lumenal domain of the HHV-7 immunoevasin U21 directs class I MHC molecules to lysosomes. Traffic 2003, 4:824-837.
23. May N.A., Wang Q., Balbo A., Konrad S.L., Buchli R., Hildebrand W.H., Schuck P., Hudson A.W. Human herpesvirus 7 U21 tetramerizes to associate with class I major histocompatibility complex molecules. J Virol 2014, 88:3298-3308.
24. Kimpler L.A., Glosson N.L., Downs D., Gonyo P., May N.A., Hudson A.W. Adaptor protein complexes AP-1 and AP-3 are required by the HHV-7 Immunoevasin U21 for rerouting of class I MHC molecules to the lysosomal compartment. PLoS One 2014, 9:e99139.
25. Schwartz O., Marechal V., Le Gall S., Lemonnier F., Heard J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 1996, 2:338-342.
26. Shen Q.T., Ren X., Zhang R., Lee I.H., Hurley J.H. HIV-1 Nef hijacks clathrin coats by stabilizing AP-1:Arf1 polygons. Science 2015, 350:aac5137.
27. Huang T., Lehmann M.J., Said A., Ma G., Osterrieder N. Major histocompatibility complex class I downregulation induced by equine herpesvirus type 1 pUL56 is through dynamin-dependent endocytosis. J Virol 2014, 88:12802-12815.
28. Huang T., Ma G., Osterrieder N. Equine Herpesvirus 1 multiply inserted transmembrane protein pUL43 cooperates with pUL56 in downregulation of cell surface major histocompatibility complex Class I. J Virol 2015, 89:6251-6263.
29. Bowers K., Piper S.C., Edeling M.A., Gray S.R., Owen D.J., Lehner P.J., Luzio J.P. Degradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTII. J Biol Chem 2006, 281:5094-5105.
30. Parkinson M.D., Piper S.C., Bright N.A., Evans J.L., Boname J.M., Bowers K., Lehner P.J., Luzio J.P. A non-canonical ESCRT pathway, including histidine domain phosphotyrosine phosphatase (HD-PTP), is used for down-regulation of virally ubiquitinated MHC class I. Biochem J 2015, 471:79-88.
31. Quinn L.L., Williams L.R., White C., Forrest C., Zuo J., Rowe M. The missing link in EBV immune evasion: the BDLF3 gene induces ubiquitination and downregulation of MHC class I and MHC class II. J Virol 2015.
32. Francica J.R., Varela-Rohena A., Medvec A., Plesa G., Riley J.L., Bates P. Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein. PLoS Pathog 2010, 6:e1001098.
33. Barel M.T., Pizzato N., Le Bouteiller P., Wiertz E.J., Lenfant F. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation. Int Immunol 2006, 18:173-182.
34. Gewurz B.E., Wang E.W., Tortorella D., Schust D.J., Ploegh H.L. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner. J Virol 2001, 75:5197-5204.
35. Ameres S., Besold K., Plachter B., Moosmann A. CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity. J Immunol 2014, 192:5894-5905.
36. Ameres S., Mautner J., Schlott F., Neuenhahn M., Busch D.H., Plachter B., Moosmann A. Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion. PLoS Pathog 2013, 9:e1003383.
37. Zuo J., Currin A., Griffin B.D., Shannon-Lowe C., Thomas W.A., Ressing M.E., Wiertz E.J., Rowe M. The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog 2009, 5:e1000255.
38. Quinn L.L., Zuo J., Abbott R.J., Shannon-Lowe C., Tierney R.J., Hislop A.D., Rowe M. Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle. PLoS Pathog 2014, 10:e1004322.
39. Griffin B.D., Gram A.M., Mulder A., Van Leeuwen D., Claas F.H., Wang F., Ressing M.E., Wiertz E. EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail. J Immunol 2013, 190:1672-1684.
40. Gainey M.D., Rivenbark J.G., Cho H., Yang L., Yokoyama W.M. Viral MHC class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming. Proc Natl Acad Sci U S A 2012, 109:E3260-E3267.
41. Gold M.C., Munks M.W., Wagner M., McMahon C.W., Kelly A., Kavanagh D.G., Slifka M.K., Koszinowski U.H., Raulet D.H., Hill A.B. Murine cytomegalovirus interference with antigen presentation has little effect on the size or the effector memory phenotype of the CD8 T cell response. J Immunol 2004, 172:6944-6953.
42. Hansen S.G., Powers C.J., Richards R., Ventura A.B., Ford J.C., Siess D., Axthelm M.K., Nelson J.A., Jarvis M.A., Picker L.J., et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 2010, 328:102-106.
43. Manley T.J., Luy L., Jones T., Boeckh M., Mutimer H., Riddell S.R. Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection. Blood 2004, 104:1075-1082.
44. Munks M.W., Pinto A.K., Doom C.M., Hill A.B. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol 2007, 178:7235-7241.
45. Busche A., Jirmo A.C., Welten S.P., Zischke J., Noack J., Constabel H., Gatzke A.K., Keyser K.A., Arens R., Behrens G.M., et al. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation. J Immunol 2013, 190:2767-2777.
46. Nopora K., Bernhard C.A., Ried C., Castello A.A., Murphy K.M., Marconi P., Koszinowski U., Brocker T. MHC class I cross-presentation by dendritic cells counteracts viral immune evasion. Front Immunol 2012, 3:348.
47. Torti N., Walton S.M., Murphy K.M., Oxenius A. Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation. Eur J Immunol 2011, 41:2612-2618.
48. Norbury C.C., Malide D., Gibbs J.S., Bennink J.R., Yewdell J.W. Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo. Nat Immunol 2002, 3:265-271.
49. Sei J.J., Haskett S., Kaminsky L.W., Lin E., Truckenmiller M.E., Bellone C.J., Buller R.M., Norbury C.C. Peptide-MHC-I from endogenous antigen outnumber those from exogenous antigen, irrespective of APC phenotype or activation. PLoS Pathog 2015, 11:e1004941.
50. Xu R.H., Remakus S., Ma X., Roscoe F., Sigal L.J. Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response. PLoS Pathog 2010, 6:e1000768.
51. Alzhanova D., Hammarlund E., Reed J., Meermeier E., Rawlings S., Ray C.A., Edwards D.M., Bimber B., Legasse A., Planer S., et al. T cell inactivation by poxviral B22 family proteins increases viral virulence. PLoS Pathog 2014, 10:e1004123.
52. Stevenson P.G., May J.S., Smith X.G., Marques S., Adler H., Koszinowski U.H., Simas J.P., Efstathiou S. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 2002, 3:733-740.
53. Hansen S.G., Ford J.C., Lewis M.S., Ventura A.B., Hughes C.M., Coyne-Johnson L., Whizin N., Oswald K., Shoemaker R., Swanson T., et al. Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine. Nature 2011, 473:523-527.
54. Hansen S.G., Piatak M., Ventura A.B., Hughes C.M., Gilbride R.M., Ford J.C., Oswald K., Shoemaker R., Li Y., Lewis M.S., et al. Immune clearance of highly pathogenic SIV infection. Nature 2013, 502:100-104.
55. + T cell epitope recognition paradigms. Science 2013, 340:1237874.
56. + T cell responses restricted by major histocompatibility complex-E. Science 2016, 351:714-720.
57. Gram A.M., Oosenbrug T., Lindenbergh M.F.S., Büll C., Comvalius A., Dickson K.J.I., Wiegant J., Vrolijk H., Lebbink R.J., Wolterbeek R., et al. A herpesvirus glycoprotein forms an immune-evasive glycan shield at the surface of infected cells. PLoS Pathog 2016, in press. 10.1371/journal.ppat.1005550.
58. Gerna G., Percivalle E., Lilleri D., Lozza L., Fornara C., Hahn G., Baldanti F., Revello M.G. Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J Gen Virol 2005, 86:275-284.
59. Tyznik A.J., Sun J.C., Bevan M.J. The CD8 population in CD4-deficient mice is heavily contaminated with MHC class II-restricted T cells. J Exp Med 2004, 199:559-565.
60. Heemskerk M.H., de Paus R.A., Lurvink E.G., Koning F., Mulder A., Willemze R., van Rood J.J., Falkenburg J.H. Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A 2001, 98:6806-6811.
61. Hirosawa T., Torikai H., Yanagisawa M., Kamei M., Imahashi N., Demachi-Okamura A., Tanimoto M., Shiraishi K., Ito M., Miyamura K., et al. Mismatched human leukocyte antigen class II-restricted CD8(+) cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation. Cancer Sci 2011, 102:1281-1286.
62. Rist M., Smith C., Bell M.J., Burrows S.R., Khanna R. Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition. Blood 2009, 114:2244-2253.
63. Tomazin R., Boname J., Hegde N.R., Lewinsohn D.M., Altschuler Y., Jones T.R., Cresswell P., Nelson J.A., Riddell S.R., Johnson D.C. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med 1999, 5:1039-1043.
64. Ressing M.E., van Leeuwen D., Verreck F.A., Gomez R., Heemskerk B., Toebes M., Mullen M.M., Jardetzky T.S., Longnecker R., Schilham M.W., et al. Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc Natl Acad Sci U S A 2003, 100:11583-11588.